Platelet count and the risk of bleeding in hospitalized patients with venous thromboembolism starting anticoagulant therapy

Pathophysiology of Haemostasis and Thrombosis

Volumn 27, Issue 2, 1997, Pages 91-98

  Monreal, Manuel ^a   Urrutia, Agustin ^a   Marti, Salvador ^a   Cuxart, Alfons ^a   Roncales, Javier ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Bleeding; Heparin; Platelet count; Therapy; Venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; DALTEPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE COUNT; THROMBOEMBOLISM; VEIN THROMBOSIS;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; FEMALE; HEMORRHAGE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOPHLEBITIS;

EID: 0030927897     PISSN: 14248832     EISSN: 14248840     Source Type: Journal    
DOI: 10.1159/000217439     Document Type: Article

References (30)

1. Bentley PG, Kakkar VV, Scully MF, MacGregor IR, Webb P, Chan P: An objective study of alternative methods of heparin administration. Thromb Res 1980;18:177-187.
2. Hull RD, Raskob GE, Hirsh J, Jay RM, Leclerc JR, Gccrts WH, Roscn-bloom D, Sackett DL, Anderson C, Harrison L, Gent M: Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med 1986;315:1109-1114.
3. Doyle J, Turpie AG, Hirsh J. Best C, Kinch D, Levine MN, Gent M: Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. Ann Intern Med 1987,107: 441-445.
4. Walker MG, Shaw JW, Thomson GJ, Cumming JG, Thomas ML: Subcutaneous calcium heparin versus intravenous sodium heparin in the treatment of established acute deep vein thrombosis of the legs: A multicentre prospective randomised trial. Br Med J 1987,294:1189-1192.
5. Lopaciuk S, Meissner AJ, Ciesielski L, Korzycki J: Subcutaneous sodium heparin versus intravenous sodium heparin in the treatment of deep vein thrombosis. Proc 6th Int Meet Danubian League Against Thromb Haemorrh Disord, Vienna, June, 1989, pp 389-393.
6. Pini M, Pattacini C, Quintavalla R, Poli T, Megha A, Tagliaferri A, Ma-notti C, Dettori AG: Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis. A randomized clinical trial. Thromb Haemost 1990;64:222-226.
7. Hommes DW. Bura A, Mazzolai L, Biiller HR, ten Cate JW: Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-anal-ysis. Ann Intern Med 1992;116: 279-284.
8. Basu D, Gallus A, Hirsh J, Cade J: A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med 1972;287:324-327.
9. Morabia A: Heparin doses and major bleedings. Lancet 1986;vol i: 1278-1279.
10. Holm HA, Abidgaard U, Kalvenes S: Heparin assays and bleeding complications in treatment of deep venous thrombosis with particular reference to retroperitoneal bleeding. Thromb Haemost 1985:54:278-281.
11. Landcfeld CS, Cook EF, Flatley M, Weisberg M, Goldman L: Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy. Am J Med 1987;82: 703-713.
12. Landefeld CS, McGuire E, Rosenblatt MW: A bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapy. Am J Med 1990;89:569-578.
13. Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J, Ginsberg J, Turpie AG, Demers C, Kovacs M, Geerts W, Kassis J, Desjardins L, Cusson J, Cruickshank M, Powers P, Brien W, Haley S, Willan A: A comparison of low-molecular-weight heparin administered primarily at home with unfractioned heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996;334:677-681.
14. Koopman MMW, Prandoni P, Piovella F, Ockelford PA, Brandjes DPM, Van der Meer J, Gallus AS, Simonneau G, Chesterman CH, Prins MH. Bossuyt PMM, de Haes H, Van den Belt AGM, Sagnard L, d’Azemar P, Biiller HR: Treatment of venous thrombosis with intravenous unfractioned heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996,334:682-687.
15. Monreal M. Lafoz E, Ruiz J, Gi-menez G: Platelet count in acute pulmonary embolism: Its relationship to recurrences. Haemostasis 1993;23:263-268.
16. Monreal M, Montserrat E, Salvador R, Bechini J, Donoso L, Callejas JM. Foz M: Real-time ultrasound for diagnosis of symptomatic venous thrombosis and for screening of patients at risk: Correlation with ascending conventional venography. Angiology 1989;40:527-533.
17. Monreal M, Ruiz J, Olazabal A, Arias A. Roca J: Deep venous thrombosis and the risk of pulmonary embolism. A systematic study. Chest 1992;102:677-681.
18. Norussis MJ: SPSS/PC V2.0 Base Manual. Chicago, SPSS Inc, 1988.
19. Statistics and Epidemiology Research Corporation and Cytel Software Corporation, EGRET. Reference Manual. Seattle, 1990.
20. Landcfeld CS, Beyth RJ: Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention. Am J Med 1993:95:315-328.
21. Walker AM, Jick H: Prediction of bleeding during heparin therapy. JAMA 1980;244:1209-1212.
22. Nelson PH, Moser KM, Stoner C, Moser KS: Risk of complications during intravenous heparin therapy. West J Med 1982; 136:189-197.
23. Holm HA, Abildgaard U, Kalvenes S: Heparin assays and bleeding complications in treatment of deep venous thrombosis with particular references to retroperitoneal bleeding. Thromb Haemost 1985;53:278-281.
24. Prandoni P, Lensing AWA, Biiller H, Carta M, Cogo A, Vigo M, Casa-ra D, Ruol A, ten Cate JW: Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis. Lancet 1992;339: 441-445.
25. Hull RD. Raskob GE. Pinco GF, Green D, Trowbridge AA, Elliott CG, Lerner RG, Hall J, Sparling T, Brettell HR, Norton J, Carter CJ, George R, Merli G, Ward J, Mayo W, Rosenbloom D, Brant R: Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 1992;326:975-982.
26. Monreal M, Lafoz E, Ruiz J, Callejas JM, Arias A: Recurrent pulmonary embolism in patients treated because of acute venous thromboembolism: A prospective study. Eur J Vase Surg 1994;8:584-589.
27. Monreal M, Moreno V, Manorell A, Lafoz E, Foz M, Ruiz J, Salvador R: Predicting pulmonary embolism in postoperative patients with deep venous thrombosis of lower limbs. Ann Vase Surg 1987;2:421-425.
28. Monreal M, Lafoz E, Casals A, Ruiz J, Arias A: Platelet count and venous thromboembolism. A useful test for suspected pulmonary embolism. Chest 1991;100:1493-1496.
29. Monreal M. Lafoz E, Roca J, Granero X, Soler JM, Salazar X, Olazabal A, Bergqvist D: Platelet count, anti-platelet therapy and pulmonary' embolism. A prospective study in patients with hip surgery'. Thromb Haemost 1995;73:380-385.
30. Monreal M, Lafoz E, Llamazares J. Roncales J, Roca J. Granero X: Preoperative platelet count and postoperative blood loss in patients undergoing hip surgery: An inverse correlation. Haemostasis 1996;26: 164-169.